Morgan Stanley analyst James Faucette maintains Accenture (NYSE:ACN) with a Overweight and maintains $400 price target.
Morgan Stanley Maintains Overweight on Accenture, Maintains $400 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.